IBAL Formulations

Our clinical API development currently consists of these formulated drug candidates.

Developed as an IBAL formulaic Zn/Cu base for pharmaceutical use.

Developed as an IBAL formulaic Zn/Cu/Mg base for pharmaceutical use.

Multiple therapeutic uses in topicals, inhalants, and injectables in drug formulations.

IBAL is an ionic delivery system of coordinated Tetra and/or Hexa Agua D block metal ligands.

We design IBAL formulaic bases with other drugs to increase therapeutic efficacy.

Clinical Nutrition

Infections

Oncology

Current Development Progress

ION-ZCM1

Contracted with CMO's in varies API regulatory classifications for cGMP use.

New Developments

50%

Drug Master File

27%

Scaled Manufacturing

75%

Topical Use

89%